UK markets open in 10 minutes

Sana Biotechnology, Inc. (SANA)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
10.04+0.04 (+0.40%)
At close: 04:00PM EDT
10.44 +0.40 (+3.98%)
After hours: 04:52PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close10.00
Open10.09
Bid10.00 x 200
Ask10.05 x 600
Day's range9.82 - 10.23
52-week range2.74 - 12.00
Volume800,822
Avg. volume1,977,977
Market cap2.222B
Beta (5Y monthly)1.61
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
All
News
  • GlobeNewswire

    Sana Biotechnology to Present at May and June 2024 Investor Conferences

    SEATTLE, May 06, 2024 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today announced that it will webcast its presentations at three investor conferences in May and June. The presentations will feature a business overview and update. Sana will present at the Citizens JMP Securities Life Sciences Conference at 11:30 a.m. ET on Monday, May 13, 2024.Sana will present at the BofA Securities 2024 Healthcar

  • GlobeNewswire

    Sana Biotechnology Reports Fourth Quarter and Full Year 2023 Financial Results and Business Updates

    Goal to treat 40-60 patients in 2024 in four trials across seven indications in oncology, B-cell mediated autoimmune diseases, and type 1 diabetes Early SC291 data from ongoing ARDENT trial in relapsed/refractory NHL and CLL suggest ability to dose safely, demonstrate the desired immune evasion profile, and early clinical efficacy using hypoimmune technology Announced SC291 IND clearance for B-cell mediated autoimmune diseases with goal to report initial clinical data in 2024 Announced SC262 IND

  • GlobeNewswire

    Sana Biotechnology to Present at the Cowen 44th Annual Health Care Conference

    SEATTLE, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today announced that it will webcast its presentation at the Cowen 44th Annual Health Care Conference at 2:50 p.m. ET on Wednesday, March 6, 2024. The presentation will feature a business overview and update by Steve Harr, Sana’s President and Chief Executive Officer. The webcast will be accessible on the Investor Relations page of